The importance of somatic mutations in the Vλ gene 2a2 in human monoclonal anti-DNA antibodies

被引:26
作者
Rahman, A
Haley, J
Radway-Bright, E
Nagl, S
Low, DG
Latchman, DS
Isenberg, DA
机构
[1] UCL, Div Med, Ctr Rheumatol, Bloomsbury Rheumatol Unit, London, England
[2] Inst Child Hlth, Med Mol Biol Unit, London, England
[3] UCL, Dept Biochem & Mol Biol, BBSRC Ctr Struct Biol, London WC1E 6BT, England
基金
英国生物技术与生命科学研究理事会;
关键词
systemic lupus erythematosus; anti-DNA antibody; somatic mutation; V-lambda gene; expression system;
D O I
10.1006/jmbi.2000.4491
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2a2 is the most commonly rearranged gene in the human V-lambda locus. It has been postulated that certain immunoglobulin genes (including 2a2) are rearranged preferentially because their germline sequences encode structures capable of binding to a range of antigens. Somatic mutation could then increase the specificity and affinity of binding to a particular antigen. We studied the properties of five IgG molecules in which the same heavy chain was paired with different light chains derived from 2a2. The pattern of somatic mutations in 2a2 was shown to be crucial in conferring the ability to bind DNA, but two different patterns of mutation each conferred this ability. Computer-generated models of the three-dimensional structures of these antibodies illustrate the ability of 2a2 to form a DNA binding site in different ways. Somatic mutations at the periphery of the DNA binding site were particularly important. In two different light chains, mutations to arginine at different sites in the complementarity determining regions (CDRs) enhanced binding to DNA. In a third light chain, however, mutation to arginine at a different site blocked binding to DNA. (C) 2001 Academic Press.
引用
收藏
页码:149 / 160
页数:12
相关论文
共 39 条
[1]  
Brezinschek HP, 1998, J IMMUNOL, V160, P4762
[2]   Analysis of the human V-H gene repertoire - Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM(+) and CD5(-)/IgM(+) B cells [J].
Brezinschek, HP ;
Foster, SJ ;
Brezinschek, RI ;
Dorner, T ;
DomiatiSaad, R ;
Lipsky, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2488-2501
[3]  
de Wildt RMT, 2000, EUR J IMMUNOL, V30, P254, DOI 10.1002/1521-4141(200001)30:1<254::AID-IMMU254>3.0.CO
[4]  
2-X
[5]   Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire [J].
de Wildt, RMT ;
Hoet, RMA ;
van Venrooij, WJ ;
Tomlinson, IM ;
Winter, G .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 285 (03) :895-901
[6]   Analysis of the targeting of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human VHDJH rearrangements [J].
Dorner, T ;
Foster, SJ ;
Brezinschek, HP ;
Lipsky, PE .
IMMUNOLOGICAL REVIEWS, 1998, 162 :161-171
[7]   HUMAN-IGG ANTI-DNA ANTIBODIES DEPOSIT IN KIDNEYS AND INDUCE PROTEINURIA IN SCID MICE [J].
EHRENSTEIN, MR ;
KATZ, DR ;
GRIFFITHS, MH ;
PAPADAKI, L ;
WINKLER, TH ;
KALDEN, JR ;
ISENBERG, DA .
KIDNEY INTERNATIONAL, 1995, 48 (03) :705-711
[8]   SEROLOGICAL AND GENETIC-CHARACTERIZATION OF A HUMAN MONOCLONAL IMMUNOGLOBULIN-G ANTI-DNA IDIOTYPE [J].
EHRENSTEIN, MR ;
LONGHURST, CM ;
LATCHMAN, DS ;
ISENBERG, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1787-1797
[9]   AN IMPROVED THERMAL CYCLE FOR 2-STEP PCR-BASED TARGETED MUTAGENESIS [J].
GOOD, L ;
NAZAR, RN .
NUCLEIC ACIDS RESEARCH, 1992, 20 (18) :4934-4934
[10]  
IBRAHIM SM, 1995, J IMMUNOL, V155, P3223